drugset / Trial / NCT00505973

Study Evaluating the Safety and Tolerability of SCA-136 in Healthy Japanese Male Subjects

NCT00505973

Phase 1 Completed 24 enrolled Wyeth is now a wholly owned subsidiary of Pfizer
RandomizedSingle-groupDouble-blindTreatment

Summary

This study is being conducted to assess the safety and tolerability of ascending multiple oral doses of SCA-136 administered to healthy Japanese male subjects.

Timeline

Start
2007-07
Primary completion
Completion
2007-10

Drugs

EvaluationDrugModalityDoseRoute
Subject vabicaserin Small molecule Oral

Indications